With or without biopsy in coeliac children?—Impact on dietary compliance and quality of life
European Journal of Pediatrics · 2024
DOI: 10.1007/s00431-024-05686-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Evelien Antonius und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Rijnstate Hospital, Wagnerlaan 55, 6815 AD, Arnhem, the Netherlands. Hauptthemen laut MEDLINE: Celiac Disease, Quality of Life, Patient Compliance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Critics of the ESPGHAN guidelines on CD question the acceptance of the no-biopsy policy by patients and parents against the backdrop of a lifelong diagnosis. The aim of this study was to investigate the impact of the no-biopsy approach on dietary adherence and health-related quality of life (HRQOL). In this retrospective cohort study, patients ≤ 18 years diagnosed with CD between 2007 and 2017 were sent two questionnaires: a dietary interview and a CD-specific HRQOL questionnaire (CDDUX). Included patients were divided into group A (with biopsies 2012) and C (without biopsies >2012). Fisher exact test and ANOVA were used to analyze the impact of the new diagnostic strategy. Forty-seven percent (82/173 patients) consented to participate in the study. Of them, 63% had a biopsy-confirmed diagnosis (40% before 2012 (group A), 23% after 2012 (group B)), and 37% were diagnosed without biopsies (group C). Dietary compliance was similar in all groups (p = 0.67). Group A scored significantly better on the subscale 'Having CD' compared to both groups diagnosed after 2012 (p = 0.003). Group A and group C seemed to score better on the total CDDUCX score when compared to group B (86 and 80% versus 61% respectively, p = 0.13). This was also observed within the subscale Diet; Group A and C scored significantly better than group B (62 and 72% versus 39% respectively, p = 0.09). CONCLUSIONS: Omitting duodenal biopsies in the diagnostic approach of our CD cohort had no adverse effect on dietary adherence and HRQOL. WHAT IS KNOWN: • Since the publication of the ESPGHAN guideline of 2012, duodenal biopsies are no longer obligatory in the diagnostic approach of CD if IgA-antibodies for transglutaminase 2 are ≥10× ULN, endomysial antibodies are positive in a second blood sample and the patient/family agrees with the no-biopsy approach. • Literature on the effect of the no-biopsy approach on dietary adherence and HRQOL is scarce. WHAT IS NEW: • Omitting duodenal biopsies does not influence dietary adherence and quality of life. • In our cohort, lower quality of life measured with the CDDUX subscale 'Having CD' is more likely to be related to shorter disease duration than to the diagnostic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, Rijnstate Hospital, Wagnerlaan 55, 6815 AD, Arnhem, the Netherlands.
- Clinical Research Center, Rijnstate Hospital, Arnhem, the Netherlands.
- Department of Paediatrics, Rijnstate Hospital, Wagnerlaan 55, 6815 AD, Arnhem, the Netherlands. mwessels@rijnstate.nl.
Zitieren
APA
Antonius, E., Kho, Y., Roovers, L., & Wessels, M. (2024). With or without biopsy in coeliac children?—Impact on dietary compliance and quality of life. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05686-1
Vancouver
Antonius E, Kho Y, Roovers L, Wessels M. With or without biopsy in coeliac children?—Impact on dietary compliance and quality of life. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05686-1
BibTeX
@article{Antonius2024,
author = {Antonius, Evelien and Kho, Yenny and Roovers, Lian and Wessels, Margreet},
title = {With or without biopsy in coeliac children?—Impact on dietary compliance and quality of life},
journal = {European Journal of Pediatrics},
year = {2024},
doi = {10.1007/s00431-024-05686-1}
}
EUVIMED